News and Views


Nature Chemical Biology 2, 295 - 296 (2006)
doi:10.1038/nchembio0606-295

Signalomic signatures enlighten drug profiling

Robert T Abraham1

  1. Robert T. Abraham is in the Department of Oncology Discovery, Wyeth, 401 N. Middletown Road, Pearl River, New York 10965, USA. e-mail: abrahar@wyeth.com.


When introduced into living cells, drugs frequently evoke unanticipated responses that are due either to off-target effects or to previously unknown interactions between the intended target and other biochemical pathways. The development of a panel of high-resolution sentinel assays for signal-transduction cascades in human cells promises to enhance the power of chemical genetics and increase the efficiency of drug-discovery research.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

TCR avidity: it's not how strong you make it, it's how you make it strong

Nature Immunology News and Views (01 Aug 2001)


Extra navigation

Subscribe to Nature Chemical Biology

Subscribe

Search PubMed for

Open Innovation Challenges

  • Efficient Chromosome Doubling: Plant Cell Division

    • Deadline: Jul 15 2009
    • Reward: $20,000 USD

    The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

natureproducts